v3.26.3
Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Dec. 31, 2025
Cash flows from operating activities          
Net loss $ (119,036) $ (162,253) $ (367,545) $ (536,637)  
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation and amortization     54,375 64,223  
Stock-based compensation     64,741 87,460  
Asset impairment     0 5,956  
Lease expense     15,838 17,019  
Loss on disposal of a business     0 4,502  
Acquired IPR&D     0 22,082  
Deferred income taxes     (4,600) 219  
Other, net     3,312 6,436  
Changes in operating assets and liabilities:          
Other receivables and assets     (5,430) 33,775  
Prepaid data assets     8,860 29,601  
Accrued data liability     0 20,258  
Unearned revenue     (14,606) (30,014)  
Accounts payable     (1,630) (7,035)  
Accrued development expense     808 (4,210)  
Accrued expenses and other current liabilities     (4,655) (23,246)  
Lease liabilities     (13,922) (16,124)  
Net cash used in operating activities     (264,454) (325,735)  
Cash flows from investing activities          
Purchases of property and equipment     (709) (5,225)  
Purchase of an intangible asset     (1,995) (2,158)  
Decrease in cash related to disposal of a business     0 (4,438)  
Purchases of investments     0 (3,806)  
Net cash used in investing activities     (2,704) (15,627)  
Cash flows from financing activities          
Proceeds from issuance of common shares, net of issuance costs     85,515 395,484  
Equity incentive plans     (355) 3,300  
Repayment of long-term debt and finance lease liabilities     (6,753) (6,258)  
Purchase of an intangible asset     0 (3,000)  
Net cash provided by financing activities     78,407 389,526  
Effect of exchange rate changes on cash, cash equivalents and restricted cash     (3,640) 15,957  
Net change in cash, cash equivalents and restricted cash     (192,391) 64,121  
Cash, cash equivalents and restricted cash, beginning of period     753,921 603,024 $ 603,024
Cash, cash equivalents and restricted cash, end of period $ 561,530 $ 667,145 561,530 667,145 $ 753,921
Supplemental schedule of non-cash investing and financing activities          
Issuance of shares for the acquisition of an asset     0 20,315  
Accrued property and equipment     669 29  
Purchase of an equity investment     $ 0 $ 4,438